small molecule

SEASONIQUE

ETHINYL ESTRADIOL; LEVONORGESTREL

Loss of exclusivityDecember 2028latest FDA-listed patent expiry
CompanyTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC

Drug detail

Brand nameSEASONIQUE
Active ingredientETHINYL ESTRADIOL; LEVONORGESTREL
Strength0.03MG,0.01MG;0.15MG,N/A
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2006
Marketing statusRX

Listed patents

PatentExpiresType
7855190December 2028use U-1

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SEASONIQUE patent cliff — loss of exclusivity December 2028 | CliffBio